Pitavastatin
Back to searchMolecule Structure
Scientific Name
Pitavastatin
Description of the Drug
Pitavastatin is an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08860
http://www.drugbank.ca/drugs/DB08860
Brand Name(s)
Not Available
Company Owner(s)
Sawai Usa Inc, Medicure International Inc, Orient Pharma Co Ltd, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Kowa Co Ltd, Lupin Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| HMG-CoA reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL402 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3369 | |||||
| Human Metabolome Database | HMDB0041991 | |||||
| DrugBank | DB08860 | |||||
| PubChem: Thomson Pharma | 14807037 | 14831666 | ||||
| PubChem | 5282452 | |||||
| LINCS | LSM-45806 | |||||
| Nikkaji | J1.195.500B | J640.860E | ||||
| PDBe | PV9 | |||||
| BindingDB | 86707 | |||||
| EPA CompTox Dashboard | DTXSID1048384 | |||||
| DrugCentral | 2214 | |||||
| ChemicalBook | CB6206668 | |||||
| Guide to Pharmacology | 3035 | |||||
| rxnorm | PITAVASTATIN MAGNESIUM | LIVALO | ZYPITAMAG | PITAVASTATIN | PITAVASTATIN CALCIUM | PITAVASTATIN SODIUM |
| ChEBI | 32020 | |||||
| ZINC | ZINC000001534965 |
